tylan 200 for injection
elanco australasia pty ltd - tylosin - tylosin 200 g/litre - antibiotic
haemoctin sdh 250 iu
kamada ltd, israel - human plasma coagulation factor viii - powder for solution for injection - human plasma coagulation factor viii 50 iu/ml - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding: in patients with haemophilia a (congenital factor viii deficiency) in patient with acquired factor viii deficiency. haemoctin is not effective in controlling the bleeding of patients with von willebrond`s disease.
haemoctin sdh 500 iu
kamada ltd, israel - human plasma coagulation factor viii - powder and solvent for solution for injection - human plasma coagulation factor viii 50 iu/ml - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding: in patients with haemophilia a (congenital factor viii deficiency) in patient with acquired factor viii deficiency.haemoctin is not effective in controlling the bleeding of patients with von willebrond`s disease.
haemoctin sdh 1000 iu
kamada ltd, israel - human plasma coagulation factor viii - powder and solvent for solution for injection - human plasma coagulation factor viii 100 iu/ml - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding: in patients with haemophilia a (congenital factor viii deficiency) in patient with acquired factor viii deficiency.haemoctin is not effective in controlling the bleeding of patients with von willebrond`s disease.
feiba 500u
takeda israel ltd - factor viii inhibitor bypassing fraction - powder and solvent for solution for injection/infusion - factor viii inhibitor bypassing fraction 500 u/vial - factor viii inhibitor bypassing activity - factor viii inhibitor bypassing activity - control of bleeding episodes in haemophilia a patients with factor viii inhibitors and also in patients with acquired factor viii inhibitors.control of bleeding in hemophilia b patients with inhibitors, if no other specific treatment is available.
feiba 1000u
takeda israel ltd - factor viii inhibitor bypassing fraction - powder and solvent for solution for injection/infusion - factor viii inhibitor bypassing fraction 1000 u/vial - factor viii inhibitor bypassing activity - factor viii inhibitor bypassing activity - control of bleeding episodes in haemophilia a patients with factor viii inhibitors and also in patients with acquired factor viii inhibitors .control of bleeding in hemophilia b patients with inhibitors, if no other specific treatment is available.
aerrane
baxter healthcare distribution ltd., israel - isoflurane - liquid for inhalation - isoflurane 100 ml / 100 ml - isoflurane - isoflurane - aerrane is a volatile halogenated anesthetic for general inhalation anesthesia.
feiba 50 units/ml pdr+solv for soln for inf
baxter healthcare limited - feiba - pdr+solv for soln for inf - 50 units/ml
feiba 25 units/ml pdr+solv for soln for inf
baxter healthcare limited - feiba - pdr+solv for soln for inf - 25 units/ml
thyrozol tablet 10 mg
merck pte. ltd. - thiamazole - tablet, film coated - 10 mg - thiamazole 10 mg